Potential cognitive benefits under investigation: Improved learning and memory consolidation Enhanced neuroplasticity and synaptic function Reduced accumulation of pathological proteins (amyloid-beta, tau) Protection against vascular damage affecting brain tissue Clinical trials exploring GLP-1 receptor agonists for Alzheimer's disease and other neurodegenerative conditions are ongoing, but evidence in humans remains inconclusive and mixed
To date, few trials have reached their primary endpoints, and little evidence has promoted the approval of drug administration agencies or the use of the tested treatments in clinical practice
JL: Writing original draft
And you don't need an expensive, painful injection to trigger it
Blood samples were taken from the base of the tail, thereby reducing pain or stress compared with other puncture sites such as the jugular vein
Subsequently, the cells were co-incubated overnight with an anti-cytochrome c antibody, followed by a 2-h incubation with an Alexa Fluor 488 conjugated secondary antibody